Dose Ranging Effects of Three Low-doses of Naturlose (Tagatose) on Glycemic Control and Safety of Naturlose (Tagatose) Over Six Months in Subjects With Mild Type 2 Diabetes Mellitus Under Control With Diet and Exercise.

Trial Profile

Dose Ranging Effects of Three Low-doses of Naturlose (Tagatose) on Glycemic Control and Safety of Naturlose (Tagatose) Over Six Months in Subjects With Mild Type 2 Diabetes Mellitus Under Control With Diet and Exercise.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs D-tagatose (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 21 Jan 2011 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
    • 10 Dec 2010 Results were reported in a Spherix media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top